Standardization and automation for liquid biopsy solutions in oncology
25 Mar 2024
Tecan brings together a diverse panel of experts to discuss strategies to accelerate the development, validation, and clinical use of liquid biopsy assays and innovative technologies. This roundtable discussion aims to provide different perspectives on how to better inform medical decisions and improve patient care and outcomes.
- 0:00 - 02:41 Introduction of Speakers
Host: Klaus Lun, Executive Vice President Life Science Division, Tecan - 02:42 - 16:00 The Future of Liquid Biopsy: Creating Standards and Overcoming Challenges
Speaker: Lauren Leiman, Executive Director, BloodPAC Consortium - 16:40 - 28:40 Liquid Biopsy for Children with Cancer Challenges and Opportunities in Clinical Implementation
Speaker: Alana Church, MD, Associate Director, Laboratory for Molecular Pediatric Profiling - 29:08 – 43:30 Applications of Liquid Biopsy in Clinical Studies
Jonathan Beer, Senior Director Diagnostic Sciences, Solid Tumors, Bristol Myers Squibb - 43:38~ Discussion Panel
- What are some of the challenges to childhood cancer research that can be helped by standardization or automation?
- What role does automation play in liquid biopsy testing? And how Tecan’s liquid biopsy solution can help.
- What are some of the challenges to greater adoption of liquid biopsy use in clinical practice?
Learn more about Tecan’s integrated solution suite for liquid biopsy workflows>>
This presentation was filmed at SLAS2024.
About the company
Tecan
Tecan is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer, Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries.
